A randomized placebo-controlled trial of sarilumab in hospitalized patients with Covid-19

S Sivapalasingam, DJ Lederer, R Bhore, N Hajizadeh… - MedRxiv, 2021 - medrxiv.org
ABSTRACT BACKGROUND Sarilumab (anti-interleukin-6 receptor-α monoclonal antibody)
may attenuate the inflammatory response in Covid-19. METHODS We performed an …
被引用次数：21 相关文章

A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

S Sivapalasingam, DJ Lederer, R Bhore… - COVID-19 …, 2021 - scholarshare.temple.edu
BACKGROUND: Sarilumab (anti-interleukin-6 receptor-α monoclonal antibody) may
attenuate the inflammatory response in Covid-19. METHODS: We performed an adaptive …
[HTML] medrxiv.org

[HTML][HTML] A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

S Sivapalasingam, DJ Lederer, R Bhore, N Hajizadeh… - medRxiv, 2021 - medrxiv.org
ABSTRACT BACKGROUND Sarilumab (anti-interleukin-6 receptor-α monoclonal antibody)
may attenuate the inflammatory response in Covid-19. METHODS We performed an …

A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

S Sivapalasingam, D Lederer, R Bhore, N Hajizadeh… - 2021 - pesquisa.bvsalud.org
A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19 |
PREPRINT-MEDRXIV loading 1 2 3 +A A -A 3.A Randomized Placebo-Controlled Trial of …
[HTML] europepmc.org

[HTML][HTML] A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

S Sivapalasingam, DJ Lederer, R Bhore, N Hajizadeh… - 2021 - europepmc.org
BACKGROUND Sarilumab (anti-interleukin-6 receptor-α monoclonal antibody) may
attenuate the inflammatory response in Covid-19. METHODS We performed an adaptive …

A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

S Sivapalasingam, D Lederer, R Bhore, N Hajizadeh… - 2021 - pesquisa.bvsalud.org
ABSTRACT BACKGROUNDSarilumab (anti-interleukin-6 receptor-monoclonal antibody)
may attenuate the inflammatory response in Covid-19. METHODSWe performed an …